Nepafenac
Nepafenac structure
|
Common Name | Nepafenac | ||
|---|---|---|---|---|
| CAS Number | 78281-72-8 | Molecular Weight | 254.284 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 562.5±50.0 °C at 760 mmHg | |
| Molecular Formula | C15H14N2O2 | Melting Point | 177-181ºC | |
| MSDS | USA | Flash Point | 294.0±30.1 °C | |
| Symbol |
GHS09 |
Signal Word | Warning | |
|
Use of nepafenac (Nevanac) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections.
Clin. Ophthalmol. 4 , 1249-52, (2010) The purpose of this study is to determine the efficacy of combining topical nepafenac with monthly intravitreal injections of ranibizumab or bevacizumab in the treatment of recalcitrant exudative macular degeneration.This was a retrospective, consecutive case... |
Journals:
More...